Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

NCT02862587 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Precision Cells
Chemotherapy
Advanced Lung Cancer

Interventions

DRUG: Chemotherapy
BIOLOGICAL: precision cells

Sponsor

Shanghai International Medical Center